RNTX RNTX Professional Fees For Services — Research And Development Expense
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by RNTX in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about RNTX's professional fees for services — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is RNTX's professional fees for services — research and development expense?
- RNTX (RNTX) reported professional fees for services — research and development expense of $0 in Q1 2026.
- How has RNTX's professional fees for services — research and development expense changed year-over-year?
- RNTX's professional fees for services — research and development expense decreased by 100.0% year-over-year, from $17K to $0.
- What does professional fees for services — research and development expense mean?
- This metric represents the external professional fees and consulting costs specifically allocated to research and development activities. It captures expenditures paid to third-party experts, clinical research organizations, or specialized consultants supporting the company's drug discovery and clinical trial programs. Monitoring this expense helps investors assess the level of outsourced technical support required to advance the company's therapeutic pipeline.